Viveve Medical (VIVE) Earns Daily Media Sentiment Rating of 0.07

Share on StockTwits

News articles about Viveve Medical (NASDAQ:VIVE) have been trending somewhat positive this week, according to Accern Sentiment Analysis. Accern rates the sentiment of media coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Viveve Medical earned a coverage optimism score of 0.07 on Accern’s scale. Accern also assigned headlines about the company an impact score of 44.5261980727548 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

Here are some of the headlines that may have impacted Accern Sentiment’s rankings:

Several research firms have recently weighed in on VIVE. Mizuho restated a “buy” rating and set a $10.00 price objective on shares of Viveve Medical in a research note on Tuesday, March 20th. Maxim Group reaffirmed a “buy” rating and set a $11.00 target price on shares of Viveve Medical in a report on Friday, March 16th. ValuEngine downgraded shares of Viveve Medical from a “sell” rating to a “strong sell” rating in a report on Thursday, March 1st. Ladenburg Thalmann Financial Services reissued a “buy” rating on shares of Viveve Medical in a report on Thursday, January 4th. Finally, Northland Securities started coverage on shares of Viveve Medical in a research report on Friday, January 5th. They issued an “outperform” rating and a $8.00 target price for the company. One research analyst has rated the stock with a sell rating and seven have assigned a buy rating to the company. The company currently has an average rating of “Buy” and a consensus target price of $10.00.

VIVE stock traded down $0.10 during trading on Friday, reaching $3.19. 219,759 shares of the company were exchanged, compared to its average volume of 297,943. The stock has a market cap of $103.70, a price-to-earnings ratio of -1.51 and a beta of -0.49. Viveve Medical has a twelve month low of $3.12 and a twelve month high of $11.16. The company has a debt-to-equity ratio of -11.13, a current ratio of 3.41 and a quick ratio of 3.16.

Viveve Medical (NASDAQ:VIVE) last announced its quarterly earnings results on Thursday, March 15th. The company reported ($0.53) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.47) by ($0.06). Viveve Medical had a negative net margin of 241.75% and a negative return on equity of 328.38%. The business had revenue of $5.10 million during the quarter, compared to analyst estimates of $5.09 million. equities research analysts anticipate that Viveve Medical will post -1.44 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This piece was originally posted by BBNS and is the sole property of of BBNS. If you are reading this piece on another site, it was stolen and republished in violation of international trademark and copyright law. The original version of this piece can be viewed at https://baseballnewssource.com/2018/04/06/viveve-medical-vive-receiving-somewhat-favorable-press-coverage-study-shows/2037821.html.

Viveve Medical Company Profile

Viveve Medical, Inc designs, develops, manufactures, and markets medical devices for the non-invasive treatment of various post-partum conditions. The company offers Viveve System, a radio frequency generator, a reusable hand piece, and single-use treatment tip, as well as other consumable accessories.

Insider Buying and Selling by Quarter for Viveve Medical (NASDAQ:VIVE)

Receive News & Ratings for Viveve Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viveve Medical and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand
Yankees Former Ace Ron Guidry Says Luis Severino Will Break His Records
Yankees Former Ace Ron Guidry Says Luis Severino Will Break His Records
Ruptured Biceps Tendon Ends Miguel Cabrera’s Season
Ruptured Biceps Tendon Ends Miguel Cabrera’s Season
Dodgers Getting Big Unexpected Lift from Three Players
Dodgers Getting Big Unexpected Lift from Three Players


Leave a Reply

 
© 2006-2018 BBNS.